Oncology Deal-Making The Daiichi Way

$13bn Deal Value In 18 Months

 
• By Ian Haydock
Monomethyl auristatin E (MMAE, vedotin), the cytotoxic payload of brentuximab vedotin antibody-drug conjugate. Atoms are represented as spheres with conventional color coding: hydrogen (white), etc
ADC Focus For Daiichi As It Pursues Oncology Goals • Source: Shutterstock

More from Business

More from Scrip